- Condition: ACL Injury
Intervention: Other: Core-PAC
Sponsors: University of British Columbia; University of British Columbia
Completed - verified May 2012 - Condition: Prediabetes
Intervention: Behavioral: Lifestyle changes
Sponsors: University of British Columbia; University of British Columbia; Canadian Institutes of Health Research (CIHR)
Not yet recruiting - verified April 2012 - Condition: Vitamin B12 Deficiency
Interventions: Dietary Supplement: L-5-methyltetrahydrofolate (Metafolin ®); Dietary Supplement: folic acid; Dietary Supplement: Placebo
Sponsors: University of British Columbia; University of British Columbia
Not yet recruiting - verified April 2012 - Conditions: Endothelial Dysfunction; Systemic Inflammation
Interventions: Device: HEPA Filter; Device: HEPA Filtration Placebo
Sponsors: Simon Fraser University; Simon Fraser University
Enrolling by invitation - verified April 2012 - Condition: Red Blood Cell Folate
Interventions: Dietary Supplement: Folic acid; Dietary Supplement: L-5-MTHF; Other: Placebo
Sponsors: University of British Columbia; University of British Columbia
Not yet recruiting - verified March 2012 - Conditions: Diabetes Mellitus Type 2; Prader Willi Syndrome
Intervention: Drug: Liraglutide
Sponsors: Vancouver General Hospital; Vancouver General Hospital; Novo Nordisk
Active, not recruiting - verified February 2012 - Condition: Hypertension
Interventions: Behavioral: e-Counseling plus Usual Care; Behavioral: Control
Sponsors: University Health Network, Toronto; University Health Network, Toronto
Not yet recruiting - verified January 2012 - Condition: Pregnancy
Intervention: Device: Lumbar 3D ultrasound scanning and palpation (Ultrasonix )
Sponsors: University of British Columbia; University of British Columbia; Canadian Institutes of Health Research (CIHR)
Not yet recruiting - verified February 2012 - Condition: Body Fat Disorder
Intervention: Device: The Zeltiq System
Sponsors: Zeltiq Aesthetics; Zeltiq Aesthetics
Enrolling by invitation - verified January 2012 - Condition: Body Fat Disorder
Intervention: Device: The Zeltiq System
Sponsors: Zeltiq Aesthetics; Zeltiq Aesthetics
Recruiting - verified January 2012 - Condition: Hemodynamic Instability
Intervention: Drug: Dexmedetomidine
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified January 2012 - Conditions: Cardiovascular Disease; Obesity; Dyslipidemia
Interventions: Behavioral: Reduced cardiac rehabilitation group intervention (rCRP).; Behavioral: Standard cardiac rehabilitation intervention
Sponsors: Simon Fraser University; Simon Fraser University
Completed - verified December 2011 - Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Behavioral: Educational intervention; Behavioral: Group one; Behavioral: Group two; Behavioral: Group three; Behavioral: Group four
Sponsors: University of British Columbia; University of British Columbia; VCH; SUCCESS; CMHPS; Mid-Main Health Centre; Provincial Health Services Authority; Bridge Clinic; Heart and Stroke Foundation of BC
Enrolling by invitation - verified November 2011 - Condition: Tobacco Use Cessation
Intervention: Behavioral: Referral to QuitNow Services
Sponsors: University of British Columbia; University of British Columbia; Vancouver Coastal Health Research Institute
Recruiting - verified December 2011 - Conditions: Streptococcal Infection; Gram-positive Bacterial Infection; Bacterial Infection
Interventions: Biological: Group B streptococcus vaccine; Biological: Placebo
Sponsors: Novartis; Novartis; Novartis Vaccines
Recruiting - verified May 2012 - Conditions: Atherosclerosis; Coronary Artery Disease; Cardiovascular Disease
Intervention:
Sponsors: Cedars-Sinai Medical Center; Cedars-Sinai Medical Center
Recruiting - verified September 2011 - Condition: Influenza
Interventions: Biological: High Dose Trivalent Inactivated Influenza Vaccine; Biological: Trivalent Inactivated Influenza Vaccine
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Active, not recruiting - verified February 2012 - Conditions: Meningococcal Disease; Meningococcal Meningitis
Intervention: Biological: Serogroup B meningococcal vaccine
Sponsors: Novartis; Novartis; Novartis Vaccines
Completed - verified January 2012 - Condition: Influenza
Intervention:
Sponsors: Fraser Health; Fraser Health; Novartis Pharmaceuticals
Not yet recruiting - verified August 2011 - Conditions: Physical Activity; Obesity; Physical Fitness
Intervention: Behavioral: Action Schools! BC
Sponsors: University of British Columbia; University of British Columbia; University of Victoria; University of Waterloo; Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of Canada; BC Ministry of Education; BC Ministry of Health; BC Ministry of Tourism, Sport, and the Arts; Provincial Health Services Authority; JW Sporta; 2010 Legacies Now
Completed - verified August 2011 - Condition: Healthy
Interventions: Dietary Supplement: All Greens; Other: Control Formulation
Sponsors: University of British Columbia; University of British Columbia; Factors Group of Nutritional Companies; QualityMetrics
Recruiting - verified April 2012 - Condition: Peristomal Skin Complication
Intervention: Device: Use of CASTLE barrier
Sponsors: Hollister Incorporated; Hollister Incorporated
Completed - verified December 2011 - Condition: Gout
Intervention: Drug: Arhalofenat4e
Sponsors: Metabolex; Metabolex
Active, not recruiting - verified November 2011 - Condition: Epidural and Spinal Anesthesia for Cesarean Delivery
Intervention:
Sponsors: University of British Columbia; University of British Columbia
Completed - verified April 2012 - Condition: Fat Reduction in the Upper Arm
Intervention: Device: The Zeltiq System
Sponsors: Zeltiq Aesthetics; Zeltiq Aesthetics
Completed - verified March 2012 - Conditions: Schizophrenia; Schizoaffective Disorder; Poor Memory
Intervention:
Sponsors: BC Mental Health and Addictions Research Institute; BC Mental Health and Addictions Research Institute; University of British Columbia; Simon Fraser University; Canadian Institutes of Health Research (CIHR)
Not yet recruiting - verified January 2011 - Condition: Rotator Cuff Tendinitis
Intervention: Procedure: shoulder injections
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified July 2011 - Conditions: Cervical Cancer; HPV Type 16/18 Infections
Intervention: Biological: GSK Biologicals' HPV vaccine 580299
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Active, not recruiting - verified March 2012 - Condition: Fat Reduction in the Abdomen
Intervention: Device: The Zeltiq System
Sponsors: Zeltiq Aesthetics; Zeltiq Aesthetics
Completed - verified January 2012 - Condition: Vaccine Exposure During Pregnancy
Intervention:
Sponsors: Dalhousie University; Dalhousie University; Li Ka Shing Foundation; PHAC/CIHR Influenza Research Network
Active, not recruiting - verified June 2011 - Condition: Physical Activity
Interventions: Behavioral: Transformational Teaching; Behavioral: Standard Educational Practices
Sponsors: University of British Columbia; University of British Columbia; Canadian Institutes of Health Research (CIHR)
Not yet recruiting - verified January 2012 - Condition: Influenza Vaccine
Interventions: Biological: Agriflu; Biological: Fluad; Biological: Intanza; Biological: Vaxigrip
Sponsors: University of British Columbia; University of British Columbia; PHAC/CIHR Influenza Research Network
Active, not recruiting - verified March 2012 - Condition: Physical Activity
Intervention: Behavioral: Exercise Videogame Bikes
Sponsors: University of Victoria; University of Victoria; Canadian Cancer Society; University of British Columbia; Dalhousie University; University of Auckland, New Zealand
Recruiting - verified June 2011 - Conditions: SCID; ADA-SCID; XSCID; Leaky SCID; Omenn Syndrome; Reticular Dysgenesis
Intervention:
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID); Office of Rare Diseases (ORD)
Recruiting - verified November 2011 - Condition: Healthy Runners
Interventions: Other: Nike Pegasus; Other: Nike Free 3.0; Other: Vibram Five Fingers Shoe
Sponsors: University of British Columbia; University of British Columbia; Nike Inc.
Active, not recruiting - verified August 2011 - Condition: Type 2 Diabetes
Interventions: Procedure: Point-of-care "finger-poke" HbA1c determination.; Procedure: HbA1c blood test; Procedure: HbA1c finger poke test; Procedure: Blood test; Procedure: Blood test
Sponsors: University of British Columbia; University of British Columbia; Vancouver General Hospital
Recruiting - verified April 2012 - Condition: Respiratory Muscle Blood Flow
Interventions: Other: Near Infrared Spectroscopy; Other: Near Infrared Spectroscopy
Sponsors: University of British Columbia; University of British Columbia
Not yet recruiting - verified December 2011 - Condition: Influenza
Intervention:
Sponsors: Dalhousie University; Dalhousie University; Canadian Institutes of Health Research (CIHR)
Active, not recruiting - verified June 2011 - Condition: Pandemic H5N1 Influenza
Interventions: Biological: GSK Biologicals' investigational vaccine GSK1557484A; Biological: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified January 2012 - Condition: Macular Edema Following Cataract Surgery
Interventions: Drug: Trientine Hydrochloride; Other: For Arm B there is no therapeutic intervention other than standard of care, which is cataract surgery.
Sponsors: University of British Columbia; University of British Columbia
Not yet recruiting - verified April 2012 - Condition: Hypotension
Intervention:
Sponsors: University of British Columbia; University of British Columbia
Completed - verified February 2012 - Condition: Labour Analgesia and Neonate Activity
Intervention:
Sponsors: University of British Columbia; University of British Columbia
Completed - verified February 2012 - Condition: Infant Nutrition
Interventions: Dietary Supplement: Nutrition supplement containing Long Chain Polyunsaturated Fatty Acids (LCPUFA); Dietary Supplement: Nutrition supplement containing Long Chain Polyunsaturated Fatty Acids (LCPUFA)
Sponsors: University of British Columbia; University of British Columbia; Martek Biosciences Corporation; DSM Food Specialties
Recruiting - verified January 2012 - Condition: Oxidative Stress
Interventions: Dietary Supplement: Lithia water; Dietary Supplement: Natural spring water with negligible lithium levels
Sponsors: University of British Columbia; University of British Columbia; Aquaceutica Group
Suspended - verified May 2012 - Condition: Confidence Using a Wheelchair
Intervention: Other: Wheelchair Skills Training Program
Sponsors: University of British Columbia; University of British Columbia
Completed - verified November 2011 - Condition: To Evaluate the Efficacy of the Expert System in Enhancing the Anesthesiologist's Ability to Detect Critical Events in a Simulated OR Environment.
Intervention:
Sponsors: University of British Columbia; University of British Columbia
Completed - verified November 2011 - Condition: Device - Intubating Laryngeal Airway
Intervention:
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified December 2011 - Conditions: Asthma; Health
Intervention: Other: All patients
Sponsors: Centocor, Inc.; Centocor, Inc.
Recruiting - verified May 2012 - Conditions: Mild Cognitive Impairment (MCI); Alzheimer's Disease
Intervention:
Sponsors: Alzheimer's Disease Cooperative Study (ADCS); Alzheimer's Disease Cooperative Study (ADCS); Northern California Institute for Research and Education (NCIRE); National Institute on Aging (NIA)
Recruiting - verified May 2012 - Condition: Cesarean
Intervention: Behavioral: Doula support
Sponsors: University of British Columbia; University of British Columbia; Provincial Health Services Authority (PHSA)
Recruiting - verified May 2012 - Condition: Diabetic Retinopathy
Interventions: Drug: Trientine Hydrochloride; Drug: Oral placebo capsules
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified June 2011 - Condition: Diabetes
Intervention: Procedure: Lispro insulin
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified November 2011 - Conditions: Influenza, Human; Seasonal Influenza
Interventions: Biological: Quadrivalent seasonal influenza vaccine GSK2282512A; Biological: Fluarix®; Biological: Fluarix-YB; Biological: Quadrivalent seasonal influenza vaccine GSK2282512A
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified August 2011 - Condition: Influenza
Interventions: Biological: Quadrivalent seasonal influenza vaccine GSK2282512A; Biological: FluLavalTM; Biological: FluLaval-YB
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified August 2011 - Condition: Anesthesia
Interventions: Drug: propofol; Drug: sevoflurane
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified December 2011 - Conditions: Human Papillomavirus (HPV) Type 16/18 Infections; Cervical Neoplasia
Intervention: Biological: GSK580299 (Cervarix™)
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified February 2012 - Conditions: SCID; Leaky SCID; Omenn Syndrome; Reticular Dysgenesis; ADA Deficiency; XSCID
Intervention:
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID); Office of Rare Diseases (ORD)
Recruiting - verified November 2011 - Condition: Colonic Neoplasia
Intervention:
Sponsors: University of British Columbia; University of British Columbia; Canadian Society of Intestinal Research
Recruiting - verified April 2012 - Condition: Seasonal Influenza
Intervention: Biological: Fluviral
Sponsors: Dalhousie University; Dalhousie University; IWK Health Centre; Canadian Institutes of Health Research (CIHR); GlaxoSmithKline
Completed - verified June 2011 - Condition: Contraception
Interventions: Device: Flexi T 380(+) IUD; Device: Nova T IUD
Sponsors: University of British Columbia; University of British Columbia; Society of Family Planning
Recruiting - verified March 2012 - Condition: Meningococcal Infections
Interventions: Biological: Meningococcal vaccine GSK 134612; Biological: Menactra®
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified June 2011 - Condition: Herpes Zoster
Interventions: Biological: Herpes Zoster Vaccine GSK1437173A; Biological: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Active, not recruiting - verified April 2012 - Condition: Herpes Zoster
Interventions: Biological: Herpes Zoster Vaccine GSK1437173A; Biological: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Active, not recruiting - verified April 2012 - Condition: Cesarean Section
Interventions: Device: TROOP® elevation pillow; Device: TROOP® elevation pillow; Device: TROOP® elevation pillow
Sponsors: University of British Columbia; University of British Columbia
Completed - verified August 2011 - Condition: Hepatocellular Carcinoma
Intervention: Drug: doxorubicin, superabsorbent polymer microspheres, embolotherapy
Sponsors: University of British Columbia; University of British Columbia
Active, not recruiting - verified November 2011 - Conditions: Asthma; Allergic Rhinitis
Intervention:
Sponsors: University of British Columbia; University of British Columbia; Allergy, Genes and Environment Network (AllerGen); Networks of Centres of Excellence (NCE)
Recruiting - verified November 2011 - Condition: Cystic Fibrosis
Intervention:
Sponsors: University of British Columbia; University of British Columbia; Cystic Fibrosis Foundation
Recruiting - verified March 2012 - Condition: Breastfeeding
Intervention:
Sponsors: University of British Columbia; University of British Columbia; Canadian Institutes of Health Research (CIHR)
Recruiting - verified February 2012 - Condition: Docosahexanoic Acid (DHA)
Intervention:
Sponsors: University of British Columbia; University of British Columbia; Canadian Institutes of Health Research (CIHR)
Recruiting - verified February 2012 - Condition: Vitamin D Deficiency
Interventions: Drug: Vitamin D; Drug: Vitamin D3; Drug: Vitamin D
Sponsors: University of British Columbia; University of British Columbia; Canadian Institutes of Health Research (CIHR)
Recruiting - verified March 2012 - Condition: Dermatitis, Atopic
Intervention: Drug: WBI-1001
Sponsors: Welichem Biotech Inc.; Welichem Biotech Inc.
Completed - verified June 2011 - Conditions: Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B; Serogroup C Meningococcal Diseases; Diphtheria; Pertussis; Pneumococcal Diseases; Tetanus
Interventions: Biological: GSK2202083A vaccine; Biological: Prevenar 13®; Biological: Infanrix hexa™; Biological: Menjugate®; Biological: Rotarix™
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified October 2011 - Conditions: Cervical Cancer; Precancerous Condition
Intervention: Device: Multispectral Digital Colposcope (MDC)
Sponsors: British Columbia Cancer Agency; British Columbia Cancer Agency; National Cancer Institute (NCI)
Not yet recruiting - verified July 2011 - Conditions: Mild Cognitive Impairment; Alzheimer's Disease
Intervention:
Sponsors: Alzheimer's Disease Cooperative Study (ADCS); Alzheimer's Disease Cooperative Study (ADCS); Northern California Institute for Research and Education (NCIRE); National Institute on Aging (NIA)
Recruiting - verified February 2012 - Condition: Familial Hypercholesterolaemia
Interventions: Drug: rosuvastatin calcium; Drug: rosuvastatin calcium; Drug: rosuvastatin calcium
Sponsors: AstraZeneca; AstraZeneca
Active, not recruiting - verified March 2012 - Condition: Pain
Interventions: Drug: Morphine; Drug: Morphine; Drug: Morphine
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified March 2012 - Condition: Pruritus
Interventions: Drug: Naloxone; Drug: Saline/Morphine
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified December 2011 - Condition: Postprandial Lipaemia
Interventions: Dietary Supplement: Butter and Vegetable oils from soy, flaxseed, high oleic safflower and canola; Dietary Supplement: In this study subjects will consume test meals containing vegetable oils (soy, flaxseed, high oleic safflower and canola) and butter; Dietary Supplement: In this study subjects will consume test meals containing vegetable oils (soy, flaxseed, high oleic safflower and canola) and butter; Dietary Supplement: In this study subjects will consume test meals containing vegetable oils (soy, flaxseed, high oleic safflower and canola) and butter
Sponsors: University of British Columbia; University of British Columbia; Flax Council of Canada
Suspended - verified November 2011 - Condition: Suture Removal
Interventions: Procedure: Suture self removal; Procedure: Suture removal by family doctor or clinic
Sponsors: Fraser Health; Fraser Health; University of British Columbia
Completed - verified June 2011 - Condition: Falls
Interventions: Behavioral: Home-based balance and strength retraining exercise program.; Behavioral: control; usual care
Sponsors: University of British Columbia; University of British Columbia; Canadian Institutes of Health Research (CIHR)
Recruiting - verified February 2012 - Condition: Intubating Laryngeal Airway
Intervention: Device: AirQ Intubating Laryngeal Airway
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified December 2011 - Condition: Influenza Infection
Interventions: Biological: GSK2340274A; Biological: GSK2340273A; Biological: Saline placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified June 2011 - Condition: Influenza Infection
Interventions: Biological: GSK2340274A; Biological: GSK2340273A
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified April 2011 - Condition: Influenza Infection
Interventions: Biological: GSK2340274A; Biological: GSK2340273A
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified January 2012 - Condition: Anesthesia
Intervention: Other: Anesthesia
Sponsors: University of British Columbia; University of British Columbia
Active, not recruiting - verified October 2011 - Condition: Repeat Abortion Rate in Women Receiving IUDs Immediately Post-abortion
Intervention: Device: Intrauterine device (IUD)
Sponsors: University of British Columbia; University of British Columbia
Not yet recruiting - verified February 2012 - Condition: Elderly
Intervention: Procedure: The Big Squeeze
Sponsors: University of British Columbia; University of British Columbia
Completed - verified November 2011 - Condition: Mild Cognitive Impairment
Interventions: Behavioral: Exercise program (AT); Behavioral: Exercise training (RT); Behavioral: Exercise training (S & R; control)
Sponsors: University of British Columbia; University of British Columbia; Pacific Alzheimer Research Foundation
Active, not recruiting - verified October 2011 - Condition: Meningococcal C Disease
Intervention: Biological: Neisvac-C (Meningococcal C Conjugate Vaccine)
Sponsors: University of British Columbia; University of British Columbia; Canadian Institutes of Health Research (CIHR)
Active, not recruiting - verified March 2012 - Conditions: Prostate Cancer; Sexual Dysfunction
Interventions: Drug: tadalafil; Other: placebo
Sponsors: National Cancer Institute (NCI); Radiation Therapy Oncology Group; National Cancer Institute (NCI)
Active, not recruiting - verified February 2012 - Condition: Type I Supracondylar Fracture of the Humerus
Interventions: Procedure: Cast; Procedure: Splint; Procedure: Tape
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified December 2011 - Condition: Mild Traumatic Brain Injury
Interventions: Behavioral: Treatment as usual; Behavioral: Cognitive-behavioural therapy
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified November 2011 - Condition: Primary Dysmenorrhea
Interventions: Drug: Estradiol valerate, Dienogest (Natazia, Qlaira, BAY86-5027); Drug: Ethinyl estradiol, Levonorgestrel (Miranova)
Sponsors: Bayer; Bayer
Completed - verified January 2012 - Condition: Attention-Deficit/Hyperactivity Disorder
Intervention:
Sponsors: University of British Columbia; University of British Columbia; Eli Lilly and Company; Pudue Pharma; Shire Development LLC
Completed - verified June 2011 - Condition: Intubating Laryngeal Airway
Intervention:
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified December 2011 - Condition: Emergence Delirium
Interventions: Drug: Propofol; Drug: sevoflurane
Sponsors: University of British Columbia; University of British Columbia
Completed - verified December 2011 - Condition: Sleep Problems
Intervention: Behavioral: Controlled crying and routines
Sponsors: University of British Columbia; University of British Columbia; Canadian Institutes of Health Research (CIHR)
Not yet recruiting - verified April 2012 - Condition: Pregnancy
Interventions: Device: LNG-IUC or Copper T380; Device: LNG-IUC or Copper T380
Sponsors: University of British Columbia; University of British Columbia; Women's Health Research Institute of British Columbia; College Of Family Physicians
Active, not recruiting - verified March 2012 - Conditions: Hypotension; Cesarean Delivery
Interventions: Device: AIx measurement with a Sphygmacor TM; Device: AIx measurement with a Sphygmacor TM
Sponsors: University of British Columbia; University of British Columbia; Children's & Women's Health Centre of British Columbia
Active, not recruiting - verified October 2011 - Condition: Abortion
Intervention:
Sponsors: University of British Columbia; University of British Columbia; Women's Health Research Institute of British Columbia
Active, not recruiting - verified October 2011 - Condition: Additional, Effective Methods to Stop Smoking
Interventions: Behavioral: Extended IVR (integrated voice response technology); Drug: Varenicline (Champix); Behavioral: IVR treatment
Sponsors: University of British Columbia; University of British Columbia; Pfizer
Completed - verified November 2011 - Condition: Pronation Control
Interventions: Device: Motion Controlling Running Shoe; Device: Neutral Running Shoe
Sponsors: University of British Columbia; University of British Columbia
Active, not recruiting - verified October 2011 - Conditions: Cardiovascular; Diabetes; Orthostatic Hypotension; Type 2 Diabetes
Intervention: Behavioral: Home-based walking program (Aerobic Exercise)
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified November 2011 - Conditions: Smoking Cessation; Insurance Coverage
Interventions: Other: Full Smoking Cessation Treatment Coverage (100%); Other: No Smoking Cessation Treatment Coverage (0%)
Sponsors: Pfizer; Pfizer
Completed - verified February 2012 - Conditions: Triage; Pediatrics
Intervention:
Sponsors: St. Justine's Hospital; St. Justine's Hospital; SickKids Foundation; Canadian Institutes of Health Research (CIHR)
Completed - verified July 2011 - Condition: Cesarean Delivery
Interventions: Procedure: Placebo block; Procedure: Ultrasound-guided TAP block
Sponsors: University of British Columbia; University of British Columbia
Active, not recruiting - verified October 2011 - Condition: Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
Intervention: Biological: GSK580299, GSK Biological's HPV vaccine
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Active, not recruiting - verified April 2012 - Condition: Bacterial Vaginosis
Interventions: Drug: Gelatin; Drug: Boric acid; Drug: Metronidazole
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified April 2012 - Condition: Influenza Virus
Interventions: Biological: GSK Biologicals' influenza vaccine GSK1557482A; Biological: Vaxigrip
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified November 2011 - Condition: Urinary Stone Disease
Intervention:
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified November 2011 - Condition: Contraception
Interventions: Drug: Qlaira (BAY86-5027, SH T00658ID); Drug: Ortho Tri Cyclen Lo
Sponsors: Bayer; Bayer
Completed - verified July 2011 - Conditions: Poliomyelitis; Haemophilus Influenzae Type b Disease; Hepatitis B; Diphtheria; Pertussis; Tetanus
Intervention: Biological: Infanrix™ hexa
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified August 2011 - Condition: Influenza Disease
Interventions: Biological: GSK Bio's influenza vaccine GSK2186877A; Biological: Fluarix TM
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified January 2012 - Condition: Influenza
Intervention: Biological: Inactivated Influenza Vaccine Trivalent Types A and B (Split Virion)
Sponsors: British Columbia Centre for Disease Control; British Columbia Centre for Disease Control
Completed - verified July 2011 - Conditions: Schizophrenia; Bipolar Disorder; Schizoaffective Disorder
Interventions: Behavioral: Genetic Counseling; Behavioral: Genetic Counseling
Sponsors: University of British Columbia; University of British Columbia
Completed - verified November 2011 - Condition: Retinoblastoma
Interventions: Genetic: DNA ploidy analysis; Genetic: DNA stability analysis; Genetic: Southern blotting; Genetic: genetic linkage analysis; Genetic: loss of heterozygosity analysis; Genetic: mutation analysis; Genetic: polymorphism analysis; Genetic: reverse transcriptase-polymerase chain reaction; Other: environmental carcinogenesis study; Other: questionnaire administration; Other: study of socioeconomic and demographic variables; Procedure: evaluation of cancer risk factors; Procedure: mutation carrier screening
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Conditions: Cognition; Aging
Interventions: Drug: tamoxifen; Drug: raloxifene
Sponsors: Wake Forest University; Wake Forest University; National Institute on Aging (NIA)
Completed - verified May 2008 - Conditions: Acute Coronary Syndrome; Myocardial Infarction; Smoking
Interventions: Drug: Bupropion HCl ER; Drug: Placebo
Sponsors: McGill University; Mark Eisenberg; Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of Quebec
Completed - verified May 2008 - Condition: Overactive Bladder
Interventions: Drug: DR-3001; Drug: DR-3001; Drug: Placebo
Sponsors: Duramed Research; Duramed Research
Completed - verified August 2011 - Condition: Vasomotor Symptoms
Interventions: Drug: desvenlafaxine succinate (DVS) SR; Drug: Placebo
Sponsors: Pfizer; Pfizer
Completed - verified July 2011 - Condition: Thalassemia
Intervention:
Sponsors: New England Research Institutes; New England Research Institutes; National Heart, Lung, and Blood Institute (NHLBI); Thalassemia Clinical Research Network
Completed - verified June 2011 - Condition: Pregnancy
Interventions: Dietary Supplement: omega 3 fatty acids; Dietary Supplement: vegetable oil
Sponsors: University of British Columbia; University of British Columbia; Canadian Institutes of Health Research (CIHR)
Active, not recruiting - verified November 2011 - Condition: Cesarean Delivery
Intervention: Procedure: Active warming with Bair Hugger blanket
Sponsors: University of British Columbia; University of British Columbia
Active, not recruiting - verified October 2011 - Condition: Meningococcal Infections
Interventions: Biological: MenACWY-CRM; Biological: MenACWY-CRM; Biological: Licensed meningococcal ACWY vaccine
Sponsors: Novartis; Novartis Vaccines
Completed - verified December 2011 - Condition: Congestive Heart Failure
Intervention: Other: NT-proBNP guided care
Sponsors: St. Michael's Hospital, Toronto; St. Michael's Hospital, Toronto; Hoffmann-La Roche
Recruiting - verified July 2009 - Condition: Ovarian Cancer
Interventions: Drug: placebo; Drug: alendronate/cholecalciferol
Sponsors: British Columbia Cancer Agency; British Columbia Cancer Agency
Completed - verified June 2011 - Conditions: Cervical Cancer; Papillomavirus Infection
Intervention: Biological: GSK Bio's HPV vaccine 580299 (Cervarix TM)
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Active, not recruiting - verified November 2011 - Condition: Spinal Cord Injury
Interventions: Behavioral: Cardiovascular training; Behavioral: Balance training
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified April 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium; Drug: Placebo
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals; Pfizer
Completed - verified November 2011 - Condition: Exostoses, Multiple Hereditary
Intervention:
Sponsors: University of British Columbia; University of British Columbia; MHE Coalition
Recruiting - verified October 2011 - Conditions: Psychosocial; Cervical Cancer
Intervention: Behavioral: Questionnaire
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center
Active, not recruiting - verified March 2012 - Condition: Cervical Cancer Screening
Interventions: Procedure: Cervical cancer screening undertaken by HPV testing as a single primary screening test with cytology triage of women who are HPV positive; Procedure: Cervical cancer screening undertaken by HPV testing as a single primary screening test with cytology triage of women who are HPV positive
Sponsors: University of British Columbia; University of British Columbia; Canadian Institutes of Health Research (CIHR)
Recruiting - verified March 2012 - Condition: Generalized Anxiety Disorder
Intervention:
Sponsors: University of British Columbia; University of British Columbia
Completed - verified April 2012 - Condition: Obsessive Compulsive Disorder
Intervention:
Sponsors: University of British Columbia; University of British Columbia
Completed - verified June 2011 - Condition: Healthy
Interventions: Behavioral: Exercise Training; Behavioral: Exercise training; Behavioral: Exercise training
Sponsors: University of British Columbia; University of British Columbia; Michael Smith Foundation for Health Research
Active, not recruiting - verified September 2011 - Condition: Adverse Drug Reaction (ADR)
Intervention:
Sponsors: University of British Columbia; University of British Columbia; Genome British Columbia; Child and Family Research Institute; University of Western Ontario, Canada; Provincial Health Services Authority; Health Canada; Canada Gene Cure; Eli Lilly and Company; Pfizer; Merck; Canadian Society of Clinical Pharmacology; Canadian Institutes of Health Research (CIHR); Canada Foundation for Innovation; British Columbia Clinical Genomics Network
Recruiting - verified March 2012 - Condition: Menstruation
Intervention: Device: Diva Cup TM
Sponsors: University of British Columbia; University of British Columbia; National Research System-College of Family Physicians of Canada
Recruiting - verified November 2011 - Conditions: Cardiovascular; Diabetic
Interventions: Behavioral: Aerobic Exercise and Strength Exercise; Behavioral: Strength training
Sponsors: University of British Columbia; University of British Columbia; Canadian Institutes of Health Research (CIHR)
Recruiting - verified December 2011 - Condition: Healthy
Intervention:
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified December 2011 - Condition: Humeral Fractures
Interventions: Procedure: Crossed K-wiring of supracondylar fracture of the humerus; Procedure: Lateral K-wiring of supracondylar fracture of the humerus
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified April 2012 - Conditions: Rubella; Varicella; Mumps; Measles
Interventions: Biological: MeMuRu-OKA (study vac); Biological: MMR, Varicella vacc (control)
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified September 2011 - Condition: Cellulitis
Intervention: Drug: Cefazolin and Moxifloxacin
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified February 2012 - Condition: Prophylaxis for HPV Infections and Associated Cervical Neoplasia
Interventions: Biological: Cervarix; Biological: Placebo control
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Active, not recruiting - verified February 2012 - Conditions: Pulmonary Disease, Chronic Obstructive; Chronic Obstructive Pulmonary Disease (COPD)
Intervention: Other: Novel endpoint determination
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified February 2012 - Condition: Urinary Incontinence
Intervention: Device: ProACT (Adjustable Continence Therapy)
Sponsors: Uromedica; Uromedica
Active, not recruiting - verified May 2011 - Condition: Postpartum Hemorrhage
Interventions: Drug: Oxytocin; Drug: Saline solution
Sponsors: University of British Columbia; University of British Columbia
Active, not recruiting - verified September 2011 - Condition: Hypertension
Intervention: Drug: Hydrochlorothiazide
Sponsors: University of British Columbia; University of British Columbia; Canadian Institutes of Health Research (CIHR)
Completed - verified September 2011 - Condition: Respiratory Tract Infection
Interventions: Dietary Supplement: COLD-fX natural health product; Dietary Supplement: COLD-fX; Other: Placebo
Sponsors: Capital Health, Canada; Capital Health, Canada; Afexa Life Sciences Inc; IWK Health Centre; Sunnybrook Health Sciences Centre; Erasmus Medical Center; University of BC Gerontology & Diabetes Research
Completed - verified July 2011 - Condition: Acne Vulgaris
Interventions: Drug: Minocycline; Drug: Minocycline plus tretinoin
Sponsors: Derm Research @ 888 Inc.; Derm Research @ 888 Inc.; Stiefel, a GSK Company
Terminated - verified February 2012 - Condition: Herpes Simplex
Intervention: Biological: GSK208141 vaccine
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified September 2011 - Condition: Herpes Simplex
Interventions: Biological: GSK208141; Biological: HavrixTM (investigational formulation); Biological: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified April 2012 - Condition: Non-small Cell Lung Cancer
Intervention:
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified November 2011 - Condition: Tuberculosis
Interventions: Drug: Moxifloxacin; Drug: Isoniazid
Sponsors: Centers for Disease Control and Prevention; Centers for Disease Control and Prevention; Department of Veterans Affairs; Bayer; National Institutes of Health (NIH)
Completed - verified June 2011 - Condition: Autonomic Dysreflexia
Intervention: Drug: Prazosin HCL
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified November 2011 - Condition: Spinal Cord Injury
Intervention:
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified November 2011 - Condition: Toxemia
Intervention: Behavioral: preeclampsia
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified March 2012 - Conditions: Obesity; Heart Diseases
Intervention: Drug: Orlistat
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified February 2012 - Condition: Menopause
Interventions: Drug: Oral Micronized Progesterone (Prometrium®); Other: Placebo
Sponsors: University of British Columbia; University of British Columbia
Active, not recruiting - verified September 2011 - Conditions: Human Papillomavirus (HPV) Infection; Cervical Neoplasia
Interventions: Biological: Cervarix™; Biological: Havrix™-based investigational formulation
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified February 2012 - Condition: Papillomavirus Infection
Intervention: Biological: HPV 16/18 VLP AS04
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified October 2011 - Condition: Urinary Incontinence
Intervention: Device: ACT (Adjustable Continence Therapy)
Sponsors: Uromedica; Uromedica
Completed - verified May 2011 - Condition: Alzheimer's Disease
Interventions: Procedure: Magnetic Resonance Imaging (MRI); Procedure: Positron Emission Tomography (PET); Procedure: Lumbar Puncture (LP)
Sponsors: Alzheimer's Disease Cooperative Study (ADCS); Alzheimer's Disease Cooperative Study (ADCS); Northern California Institute for Research and Education (NCIRE); National Institute on Aging (NIA); National Institute for Biomedical Imaging and Bioengineering (NIBIB); Foundation for the National Institutes of Health; Alzheimer’s Drug Discovery Foundation; Alzheimer's Association
Completed - verified January 2012 - Conditions: Cervical Cancer; Precancerous Condition
Interventions: Procedure: Colposcopic biopsy; Procedure: Light-Scattering Spectroscopy
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Completed - verified July 2011 - Condition: Breast Cancer
Intervention: Drug: exemestane
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group; Grupo Espanol de Investigacion del Cancer de Mama; UNICANCER
Active, not recruiting - verified August 2011 - Condition: Leukemia
Interventions: Drug: asparaginase; Drug: busulfan; Drug: cyclophosphamide; Drug: cyclosporine; Drug: cytarabine; Drug: daunorubicin hydrochloride; Drug: etoposide; Drug: gemtuzumab ozogamicin; Drug: methotrexate; Drug: mitoxantrone hydrochloride; Procedure: allogeneic bone marrow transplantation
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Completed - verified November 2010 - Condition: Leukemia
Interventions: Biological: filgrastim; Drug: asparaginase; Drug: cyclophosphamide; Drug: cyclosporine; Drug: cytarabine; Drug: daunorubicin hydrochloride; Drug: dexamethasone; Drug: etoposide; Drug: ifosfamide; Drug: imatinib mesylate; Drug: leucovorin calcium; Drug: mercaptopurine; Drug: methotrexate; Drug: pegaspargase; Drug: vincristine sulfate; Procedure: allogeneic bone marrow transplantation; Procedure: peripheral blood stem cell transplantation; Procedure: umbilical cord blood transplantation; Radiation: radiation therapy
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Completed - verified November 2010
 |
Join Clinical Trials for Healthy Volunteers in British Columbia |
